bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.020
-0.160 (-7.34%)
At close: May 5, 2026, 4:00 PM EDT
2.030
+0.010 (0.50%)
After-hours: May 5, 2026, 7:40 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $9.08 million as of May 5, 2026. Its market cap has decreased by -1.11% in one year.
Market Cap
9.08M
Enterprise Value
3.92M
1-Year Change
-1.11%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $9.08M, a decrease of -79.84%. That is a compound annual growth rate of -35.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 9.80M | 84.84% |
| Dec 31, 2025 | 5.30M | -62.63% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodesix | 113.91M |
| MDxHealth | 104.78M |
| Exagen | 74.56M |
| Precipio | 52.98M |
| XWELL | 10.54M |
| Inotiv | 10.39M |
| Check-Cap | 10.13M |
| Advanced Biomed | 8.13M |